IsoRay Inc Valuation

ISRDelisted Stock  USD 0.38  0.01  2.70%   
IsoRay seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of IsoRay Inc from evaluating the firm fundamentals such as Current Valuation of (11.02 M), return on asset of -0.11, and Return On Equity of -0.17 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage buying undervalued assets and selling overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Overvalued
Today
0.38
Please note that IsoRay's price fluctuation is very steady at this time. Calculation of the real value of IsoRay Inc is based on 3 months time horizon. Increasing IsoRay's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for IsoRay Inc is useful when determining the fair value of the IsoRay stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of IsoRay. Since IsoRay is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IsoRay Stock. However, IsoRay's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.38 Real  0.3 Hype  0.38
The real value of IsoRay Stock, also known as its intrinsic value, is the underlying worth of IsoRay Inc Company, which is reflected in its stock price. It is based on IsoRay's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of IsoRay's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence IsoRay's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.30
Real Value
0.42
Upside
Estimating the potential upside or downside of IsoRay Inc helps investors to forecast how IsoRay stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IsoRay more accurately as focusing exclusively on IsoRay's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.380.380.38
Details

IsoRay Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining IsoRay's current stock value. Our valuation model uses many indicators to compare IsoRay value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IsoRay competition to find correlations between indicators driving IsoRay's intrinsic value. More Info.
IsoRay Inc is currently regarded as number one stock in price to earning category among related companies. It is currently regarded as number one stock in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value IsoRay by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for IsoRay's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IsoRay's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates IsoRay's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in IsoRay and how it compares across the competition.

About IsoRay Valuation

The delisted stock valuation mechanism determines the current worth of IsoRay Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of IsoRay Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of IsoRay Inc based exclusively on its fundamental and basic technical indicators. By analyzing IsoRay's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of IsoRay's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of IsoRay. We calculate exposure to IsoRay's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to IsoRay's related companies.
Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. Isoray, Inc. was founded in 1998 and is based in Richland, Washington. Isoray operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 66 people.

8 Steps to conduct IsoRay's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates IsoRay's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct IsoRay's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain IsoRay's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine IsoRay's revenue streams: Identify IsoRay's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research IsoRay's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish IsoRay's growth potential: Evaluate IsoRay's management, business model, and growth potential.
  • Determine IsoRay's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate IsoRay's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

IsoRay Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as IsoRay does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding142 M
Retained Earnings-98.6 M
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in IsoRay Stock

If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum